Fundraising Fox
Torigen Pharmaceuticals
Farmington, US · Delaware corporation · 7 known investors
Find your way into Torigen Pharmaceuticals
Each arrow is one introduction. Sign up to fill in the first one.
Ask Arturo Elizondo to introduce you to Ashley Kalinauskas
You →Arturo · together at Forbes 30 Under 30 2020 · Science →Ashley
Sign up to find every way you can get introduced to Torigen Pharmaceuticals
- Your email: who you already know at Torigen Pharmaceuticals, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Torigen Pharmaceuticals team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
Investors · 7
How we know: Chloe Capital's portfolio page · Not right? Tell us
How we know: Connecticut Innovations's portfolio page · funding news · press coverage · Not right? Tell us
How we know: Emerald Development Managers's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
__Twitter.png)
How we know: funding news · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · funding news · press coverage · the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$10.9M disclosed across 4 of 5 rounds · 2019–2022
▶$4.6MraisedMay 2022 · 30 investors · PharmaceuticalsRule 506(b)
- Blake HawleyDirector
- Kevin CrowleyDirector
- John KallassyExecutive Officer
- Musan DuricDirector
- Ashley KalinauskasExecutive Officer, Director
- Elizabeth GalbutDirector
- Offering amount
- $10M
- Amount sold
- $4.6M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedDec 2021 · 16 investors · PharmaceuticalsRule 506(b)
- Ashley KalinauskasExecutive Officer, Director
- Kevin CrowleyDirector
- Mark SuckowExecutive Officer, Director
- John KallassyExecutive Officer
- Blake HawleyDirector
- Elizabeth GalbutDirector
- Offering amount
- $1.5M
- Amount sold
- $1.2M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.3MraisedMar 2021 · 38 investors · PharmaceuticalsRule 506(b)
- Ashley KalinauskasExecutive Officer, Director
- Mark SuckowExecutive Officer, Director
- John KallassyExecutive Officer
- Elizabeth GalbutDirector
- Kevin CrowleyDirector
- Blake HawleyDirector
- Offering amount
- $3.5M
- Amount sold
- $3.3M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedJan 2019 · 9 investors · PharmaceuticalsRule 506(b)
- Ashley KalinauskasExecutive Officer
- Mark SuckowExecutive Officer, Director
- Brad PoffExecutive Officer
- Terry DewExecutive Officer
- Offering amount
- $2M
- Amount sold
- $1.8M
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Companies working in the same space as Torigen Pharmaceuticals.
In the news
Frequently asked questions
- Who founded Torigen Pharmaceuticals?
- Torigen Pharmaceuticals was founded by Ashley Kalinauskas.
- Who are Torigen Pharmaceuticals's investors?
- Torigen Pharmaceuticals's investors include Chloe Capital, Connecticut Innovations, Emerald Development Managers, Launchpad Venture Group, Gaingels, SoGal Ventures, The Fund.
- How much funding has Torigen Pharmaceuticals raised?
- Torigen Pharmaceuticals has disclosed $10.9M raised across 4 of its 5 known rounds.
- Where is Torigen Pharmaceuticals headquartered?
- Torigen Pharmaceuticals is headquartered in Farmington, US.